Breaking News
March 23, 2019 - Excess hormones could cause a condition that can lead to blindness in women, study finds
March 23, 2019 - Dramatic shifts in first-time opioid prescriptions bring hope, concern
March 23, 2019 - Antidepressant drugs may not work when neurons are out of shape
March 23, 2019 - TTUHSC El Paso to establish endowed chair in neurology through a major grant
March 23, 2019 - New device approved by FDA for treating patients with moderate-to-severe heart failure
March 23, 2019 - People with peripheral artery disease have lower Omega-3 Index, shows research
March 23, 2019 - Trigger warnings have minimal impact on how people respond to content, shows research
March 23, 2019 - Gilead Announces Data From Two Studies Supporting Further Development of GS-6207, a Novel, Investigational HIV-1 Capsid Inhibitor as a Component of Future Long-Acting HIV Therapies
March 23, 2019 - Selfish genetic elements amplify inflammation and age-related diseases
March 23, 2019 - Study provides new understanding of how the brain recovers from damage caused by stroke
March 23, 2019 - CRISPR/Cas libraries could revolutionize drug discovery
March 23, 2019 - Allergic reaction during pregnancy may alter sexual-development in offspring’s brain
March 23, 2019 - Seeing through a robot’s eyes helps those with profound motor impairments
March 23, 2019 - Recent research shows that ease of breastfeeding after C-section differs culturally
March 23, 2019 - Newly discovered parameters offer more control over efficient release of drugs
March 23, 2019 - ‘De-tabooing’ of abortion- Women would like more support from health care community
March 23, 2019 - Anti-TB drugs can increase susceptibility to Mtb reinfection
March 23, 2019 - New survey indicates need of attention to neglected tropical diseases
March 23, 2019 - Innovative in vitro method to develop easy-to-swallow medicine for children and older people
March 23, 2019 - Sugary drinks could raise risk of early deaths finds study
March 23, 2019 - Lian wins ENGINE grant for stem-cell-based therapy to treat Type 1 diabetes
March 23, 2019 - Overall, Physicians Are Happy and Enjoy Their Lives
March 23, 2019 - Researchers discover how blood vessels protect the brain during inflammation
March 23, 2019 - CDC study shows modest improvement in optimal hospital breastfeeding policy
March 23, 2019 - Family-based prevention program to reduce alcohol use among older teens
March 23, 2019 - Remote monitoring of implanted defibrillators in heart failure patients prevents hospitalizations
March 23, 2019 - Appropriate doffing of personal protective equipment may reduce healthcare worker contamination
March 23, 2019 - Window screens can suppress mosquito populations, reduce malaria in Tanzania
March 23, 2019 - Researchers discover new biomarker for postoperative liver dysfunction
March 23, 2019 - Pregnancy history may be linked to cognitive function in older women, finds study
March 23, 2019 - Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack
March 23, 2019 - FDA Approves First Drug for Postpartum Depression, Zulresso (brexanolone)
March 23, 2019 - New guidelines outline new treatment management for psoriasis
March 23, 2019 - Thermally abused cooking oil may promote progression of breast cancer
March 23, 2019 - High-fructose corn syrup fuels growth of colon tumors in mice
March 23, 2019 - Partnership aims at establishing best practices to promote diversity in clinical trials
March 23, 2019 - New study examines presence of microbes in tap water from residences, office buildings
March 23, 2019 - Early life trauma may affect brain structure, contribute to major depressive disorder
March 23, 2019 - NIH starts clinical trial of drug to treat cravings associated with opioid use disorder
March 23, 2019 - Cervix bacteria, immune factors could be a warning signal of premature birth, reports new research
March 23, 2019 - Worst-ever emergency care performance figures underscore the need to focus on staffing
March 23, 2019 - The Current issue of “The view from here” is concerned with Cancer
March 23, 2019 - Mouse model validates how ‘good’ and ‘bad’ bacteria affect acne
March 23, 2019 - Individual amygdala neurons respond to touch, imagery and sounds
March 23, 2019 - Combination of two topical creams can prevent cancer
March 23, 2019 - Study suggests depression screening when assessing African-Americans for schizophrenia
March 23, 2019 - New electronic support system for choosing drug treatment based on patient’s genotype
March 23, 2019 - First-of-its-kind study provides pregnancy statistics of imprisoned U.S. women
March 23, 2019 - Marinus Pharmaceuticals Initiates Phase 3 Study in Children with PCDH19-Related Epilepsy
March 23, 2019 - Laparoscopy: MedlinePlus Lab Test Information
March 23, 2019 - Shellfish allergies: can they be treated?
March 23, 2019 - Toilet seat heart monitoring system
March 23, 2019 - Researchers identify way to improve common treatment for PTSD
March 23, 2019 - High potency cannabis use linked to psychosis finds study
March 23, 2019 - Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
March 23, 2019 - Tracking HIV’s ever-evolving genome in effort to prioritize public health resources
March 23, 2019 - Scientists grow most sophisticated brain organoid to date
March 23, 2019 - ADHD drug raising risk of psychosis
March 22, 2019 - FDA approves brexanolone, first drug developed to treat postpartum depression
March 22, 2019 - Gruesome cat and dog experiments by the USDA exposed
March 22, 2019 - Ball pits used in children’s physical therapy may contribute to germ transmission
March 22, 2019 - Long-term use of inexpensive weight-loss drug may be safe and effective
March 22, 2019 - FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
March 22, 2019 - Anti-Müllerian Hormone Test: MedlinePlus Lab Test Information
March 22, 2019 - Finding the right exercise, diet aids for HIV patients
March 22, 2019 - Health Plans For State Employees Use Medicare’s Hammer On Hospital Bills
March 22, 2019 - Researchers develop new tool for imaging large groups of neurons in living animals
March 22, 2019 - Certain bacteria and immune factors in vagina may cause or protect against preterm birth
March 22, 2019 - Research identifies guidelines for prioritizing hepatitis C treatment in U.S. prisons
March 22, 2019 - Novel breath test could pave new way to non-invasively measure gut health
March 22, 2019 - Pharmaceutical and personal care products may result in new contaminants in waterways
March 22, 2019 - New model could revolutionize the way researchers investigate spread of pathogens
March 22, 2019 - MSU professor receives NSF CAREER grant for biosensor diagnostics
March 22, 2019 - High-fat, high-sugar diet in mouse mothers causes problems in the hearts of offspring
March 22, 2019 - ACC: Catheter Ablation Does Not Cut Mortality, Stroke in A-Fib
March 22, 2019 - Wiedemann-Rautenstrauch syndrome – Genetics Home Reference
March 22, 2019 - Health insurance is not assurance of healthcare
March 22, 2019 - Supporting “curiosity-driven research” at the Discovery Innovation Awards
March 22, 2019 - Must-Reads Of The Week (Some Flying Below The Radar)
March 22, 2019 - Newly engineered nanoscale protein micelles can be tracked by MRI
Experts issue new guidelines for use of genetic testing in psychiatric care

Experts issue new guidelines for use of genetic testing in psychiatric care

image_pdfDownload PDFimage_print

An expert committee of psychiatrists and geneticists has issued revised guidelines for the use of genetic testing in psychiatric care. The new guidelines, which represent the first complete revision since 2014, address several controversial questions, including the use of genetic testing to guide treatment decisions (pharmacogenetics), diagnosis of mental disorders with powerful new molecular genetic technologies, and the special ethical challenges posed by genetic testing in psychiatric patients. The guidelines are written especially for non-specialist health care providers who may find the growing menu of clinical genetic tests confusing and difficult to evaluate, while facing a spike in genetic testing requests by patients and their families.

The committee, an official body within the International Society of Psychiatric Genetics (ISPG), issued its first guidelines in 2013. Co-chaired by genetics researcher and psychiatrist Dr. Francis J. McMahon and medical geneticist Dr. Franziska Degenhardt, the committee includes over 50 international experts from the fields of precision medicine, pharmacogenomics, psychiatry, neurodevelopment, and medical genetics. Contributors reviewed the most up-to-date scientific evidence and debated a number of controversial points for months in an attempt to reach consensus on key issues.

Dr. Thomas G. Schulze, professor of psychiatry at the University of Munich and President of the ISPG called the statement a demonstration of ISPG’s “commitment to provide meaningful guidance to health care providers who urgently need it to treat their patients in the best possible ways.” He also cautioned that while “psychiatric genetics has made major progress over the last decade and we can start using the knowledge gained for the benefit of our patients, we should not succumb to overly optimistic claims. That’s the main message of this statement.”

The current guidelines are the first to be issued since the advent of widespread chromosomal testing for autism and other neurodevelopment disorders. The guidelines also address emerging issues raised by growing interest in direct-to-consumer tests, which do not require a doctor’s order, and by aggressive marketing of commercial genetic testing panels that purport to help doctors select safer and more effective medicines for psychiatric patients.

For the first time, the committee failed to reach consensus on some key questions. Although genetic testing for small chromosomal deletions and duplications – known as copy number variants or CNVs — is now widely used in children with autism and other neurodevelopmental disorders, committee members could not agree on CNV testing in most adults with mental illness. Some have argued that identification of particular CNVs in adults with major mental illnesses such as schizophrenia may help patients and their families better understand and accept a psychiatric diagnosis. If such a CNV is found in a family, those who carry it face a substantially greater risk of both mental illness and, in some cases, medical problems. On the other hand, these CNVs are very uncommon in adults with mental illness and do not as yet change the way psychiatrists treat patients.

The committee also failed to reach consensus on the widespread use of genetic tests designed to help doctors choose the safest and most effective medications for treating mental illnesses. Such tests have been aggressively marketed to both doctors and patients in recent years, even though evidence in support of better treatment outcomes has been inconclusive. The committee did agree that some specific pharmacogenetic tests should be used when doctors are considering prescribing drugs such as carbamazepine, since those tests have been proven to identify people at substantially increased risk for rare but serious side effects.

“The fact that the committee could not reach consensus on every aspect,” noted Schulze, “speaks to the complexity of the issues.”

Not everything was controversial. The committee recommended that genome-wide testing should be accompanied by professional counseling and a warning that unexpected findings may arise with implications for long-term health (such as cancer). Committee members also agreed that direct-to-consumer testing provided no health benefits to psychiatric patients, that genetic test results must be safeguarded against unauthorized disclosure, that there was a need for more genetic education of mental health professionals and the general public, and that more research was needed to identify relevant genes and clarify the proper role of genetic testing in psychiatric care.

Tagged with:

About author

Related Articles